[Bone disease in secondary hyperparathyroidism].
Hayakawa
Hiroshi
H
Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine.
Shigematsu
Takashi
T
Kazama
Junichiro James
JJ
D000818:Animals; D002117:Calcitriol / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D006801:Humans; D006961:Hyperparathyroidism / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D015552:Injections, Intralesional; D007676:Kidney Failure, Chronic / Q000150:complications; D010002:Osteitis Fibrosa Cystica / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D016105:Parathyroidectomy; D010758:Phosphorus / Q000097:blood; D020551:Pulse Therapy, Drug; D018167:Receptors, Calcitriol; D044169:Receptors, Calcium-Sensing; D006435:Renal Dialysis / Q000009:adverse effects
D018167:Receptors, Calcitriol; D044169:Receptors, Calcium-Sensing; D010758:Phosphorus; D000431:Ethanol; D002117:Calcitriol